证券代码：300596 证券简称：利安隆 公告编号：2025-073 一、拟续聘会计师事务所的基本情况 （一）机构信息 天津利安隆新材料股份有限公司 关于拟续聘会计师事务所的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1.公司 2024 年度财务报告的审计意见为标准的无保留意见； 2.本次聘任不涉及变更会计师事务所； 3.公司审计委员会、独立董事、董事会对本次续聘会计师事务所事项不存在 异议，该事项尚需提交公司 2025 年第四次临时股东会审议； 4.本次续聘会计师事务所事项符合财政部、国务院国资委、证监会印发的《国 有企业、上市公司选聘会计师事务所管理办法》（财会〔2023〕4 号）的规定。 天津利安隆新材料股份有限公司（以下简称"公司"）于 2025 年 11 月 17 日召开第五届董事会第四次会议，审议通过了《关于拟续聘会计师事务所的议案》。 公司董事会同意续聘天职国际会计师事务所（特殊普通合伙）（以下简称"天职 国际"）为公司 2025 年度审计机构，聘期一年，并将该议案提交公司 2025 年第 四次临时股东会审议，现将相关事项公 ...

证券代码：300596 证券简称：利安隆 公告编号：2025-077 天津利安隆新材料股份有限公司 关于召开 2025 年第四次临时股东会的通知 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 一、召开会议的基本情况 （1）截止股权登记日 2025 年 12 月 2 日（星期二）下午 15:00 深圳证券交易所收市 时，在中国证券登记结算有限责任公司深圳分公司登记在册的公司全体普通股股东均有权 出席股东会，并可以以书面形式委托代理人出席会议和参加表决，该股东代理人不必是本 公司股东，或在网络投票时间内参加网络投票。 1.股东会届次：2025 年第四次临时股东会 2.股东会的召集人：董事会 3.会议召开的合法、合规性：本次股东会会议召开经公司第五届董事会第四次会议审 议，符合《中华人民共和国公司法》、《深圳证券交易所创业板股票上市规则》等有关法 律、行政法规、部门规章、规范性文件和公司章程的规定。 4.会议时间： （1）现场会议时间：2025 年 12 月 08 日 15:00 （2）网络投票时间：通过深圳证券交易所系统进行网络投票的具体时间为 2025 年 1 ...

天津利安隆新材料股份有限公司 第五届董事会第四次会议决议公告 本公司及全体董事会成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 一、 会议召开情况 天津利安隆新材料股份有限公司（以下简称"公司"）第五届董事会第四次 会议于 2025 年 11 月 14 日以电话及电子邮件的方式发出通知，会议通知中包括 会议的相关资料，同时列明会议的召开时间、地点、内容和方式。会议于 2025 年 11 月 17 日上午 10:00 以现场会议及通讯会议相结合方式在公司会议室召开， 采用现场投票的方式进行表决。本次会议应出席董事 7 名，实际出席董事 7 名。 会议由董事长李海平先生主持，公司高级管理人员列席会议。 证券代码：300596 证券简称：利安隆 公告编号：2025-076 本次会议的召开和表决程序符合《公司法》等法律、法规和《公司章程》的 有关规定。 二、 会议审议情况 1.审议通过《关于拟续聘会计师事务所的议案》 经审议，董事会认为天职国际会计师事务所（特殊普通合伙）具备证券、期 货相关业务执业资格，具有上市公司审计工作的丰富经验和职业素养。其在担任 公司 2024 年度审计机构期 ...

Core Points - The company and its subsidiaries are expected to engage in daily related transactions with affiliated parties Hebei Kaide and Xinjie Yunde, with a total amount not exceeding 200 million yuan by 2026 [1] - The transactions with Hebei Kaide are expected to be no more than 150 million yuan, while those with Xinjie Yunde are expected to be no more than 50 million yuan, primarily for the procurement of raw materials [1] - From January to October 2025, the company has already conducted actual transactions amounting to 63.2531 million yuan with affiliated parties [1] - The anticipated transactions have been approved by the board of directors and do not require submission to the shareholders' meeting, thus not constituting a major asset reorganization [1]

Core Viewpoint - The company, Lianlong, reported a revenue of 5.278 billion yuan for 2023, reflecting a year-on-year growth of 9%, driven by increased production and sales of its products [1] Revenue Summary - The projected revenue for 2024 is 5.687 billion yuan, indicating a year-on-year growth of 7.74% [1] - For the first three quarters of 2025, the company achieved a revenue of 4.509 billion yuan, which is a year-on-year increase of 5.72% [1] Business Segment Performance - The core business segments, including polymer material anti-aging additives and lubricant additives, have shown stable growth [1] - The lubricant additives segment experienced a significant revenue increase of 15.40% year-on-year, contributing notably to the overall performance [1]

Core Viewpoint - Lianlong's stock price has shown a significant increase of 32.59% year-to-date, despite a recent decline of 2.13% over the last five trading days, indicating volatility in the market performance of the company [2]. Financial Performance - For the period from January to September 2025, Lianlong achieved a revenue of 4.509 billion yuan, representing a year-on-year growth of 5.72%. The net profit attributable to shareholders was 392 million yuan, reflecting a substantial increase of 24.92% [2]. - Cumulative cash dividends since the company's A-share listing amount to 450 million yuan, with 243 million yuan distributed over the past three years [3]. Stock Market Activity - As of November 5, Lianlong's stock price was 39.95 yuan per share, with a market capitalization of 9.173 billion yuan. The trading volume was 37.688 million yuan, with a turnover rate of 0.43% [1]. - The net outflow of main funds was 2.2304 million yuan, with large orders accounting for 6.53% of total purchases and 12.44% of total sales [1]. Shareholder Information - As of September 30, 2025, the number of shareholders was 14,200, a decrease of 20.10% from the previous period. The average circulating shares per person increased by 25.15% to 15,752 shares [2]. - Hong Kong Central Clearing Limited is the tenth largest circulating shareholder, holding 2.1619 million shares as a new shareholder [3]. Business Overview - Lianlong, established on August 8, 2003, and listed on January 19, 2017, specializes in the research, production, and sales of polymer material anti-aging chemical additives. The main business revenue composition includes 78.97% from anti-aging additives, 20.72% from lubricant additives, and 0.31% from other sources [2]. - The company is classified under the basic chemical industry, specifically in the category of other chemical products, and is associated with concepts such as new materials, margin financing, smart glasses, small-cap stocks, and OLEDs [2].

Group 1 - The core transaction involved 358,700 shares of Lianlong, with a total transaction value of 13.78 million yuan, accounting for 6.14% of the total trading volume on that day [1][2] - The transaction price was 38.42 yuan, which represents a 5% discount compared to the market closing price of 40.44 yuan [1][2] Group 2 - The transaction occurred on October 28, 2025, under the stock code 300596 for Lianlong [2] - The buyer was CITIC Securities Co., Ltd., and the seller was Guotou Securities Co., Ltd. [2]

Core Viewpoint - The company, Lianlong, announced that it and its subsidiaries do not have any overdue guarantees or guarantees related to litigation [2] Summary by Categories - **Company Announcement** - Lianlong released a statement confirming the absence of overdue guarantees [2] - The company also stated that there are no guarantees involved in any litigation [2]

Group 1: Financial Performance - The company achieved a revenue of 4.509 billion yuan in the first three quarters of 2025, representing a year-over-year increase of 5.72% [1] - The net profit attributable to shareholders for the same period was 392 million yuan, showing a year-over-year growth of 24.92% [1] - In Q3 alone, the company reported a revenue of 1.514 billion yuan, with a year-over-year increase of 4.77%, and a net profit of 151 million yuan, reflecting a significant year-over-year growth of 60.83% [1] Group 2: Profitability and Margin Improvement - The company's overall gross margin increased by 0.59 percentage points to 21.72%, contributing to the net profit growth [1] - The gross margin for Q1, Q2, and Q3 of 2025 showed a consistent upward trend at 21.52%, 21.65%, and 21.97% respectively [1] Group 3: Business Expansion and Development - The lubricating oil additive business is expanding well, with the second phase of the Jinzhou Kangtai project expected to start production in 2024, leading to increased capacity utilization [1] - The company is actively developing major clients and participating in the establishment of national standards for engine lubricants in China, collaborating closely with major international and domestic companies [1] - The company has made positive progress in new business areas, including life sciences and polyimide materials, with plans for production bases and R&D centers in both domestic and international locations [2]

Investment Rating - The report maintains a "Strong Buy" rating for the company [4][12]. Core Insights - The company has demonstrated steady revenue growth, with a year-on-year increase of 5.72% in the first three quarters of 2025, achieving a total revenue of 4.509 billion yuan. The net profit attributable to shareholders increased by 24.92% year-on-year, reaching 392 million yuan [2][3]. - The company's gross profit margin improved by 0.59 percentage points to 21.72%, contributing to the net profit growth. The quarterly gross profit margins for Q1, Q2, and Q3 of 2025 were 21.52%, 21.65%, and 21.97%, respectively [3]. - The company is expanding its lubricant additive business, with the second phase of the Jinzhou Kangtai project expected to commence production in 2024. The company is actively developing major clients and participating in the establishment of industry standards in China [3]. - The company is making positive strides in emerging business areas, including life sciences and polyimide materials. The life sciences segment is transitioning from R&D to market development, while a new production base and R&D center for polyimide materials are being established in Yixing, with trial production expected in 2026 [4]. - The company is also planning to build an overseas R&D and production base in Malaysia for high-performance polymer materials and lubricant additives [4]. Financial Forecasts - The company is projected to achieve net profits of 528 million yuan, 619 million yuan, and 713 million yuan for the years 2025, 2026, and 2027, respectively, with corresponding earnings per share (EPS) of 2.30 yuan, 2.69 yuan, and 3.11 yuan [4][11]. - The current price-to-earnings (P/E) ratios for 2025, 2026, and 2027 are estimated to be 17, 15, and 13 times, respectively [4].